India · Delayed Price · Currency is INR Sheel Biotech Statistics
Total Valuation
Sheel Biotech has a market cap or net worth of INR 1.24 billion. The enterprise value is 1.24 billion.
| Market Cap | 1.24B |
| Enterprise Value | 1.24B |
Important Dates
The next estimated earnings date is Friday, September 25, 2026.
| Earnings Date | Sep 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Sheel Biotech has 20.35 million shares outstanding. The number of shares has increased by 19.13% in one year.
| Current Share Class | 20.35M |
| Shares Outstanding | 20.35M |
| Shares Change (YoY) | +19.13% |
| Shares Change (QoQ) | +42.39% |
| Owned by Insiders (%) | 62.83% |
| Owned by Institutions (%) | n/a |
| Float | 5.85M |
Valuation Ratios
The trailing PE ratio is 9.12.
| PE Ratio | 9.12 |
| Forward PE | n/a |
| PS Ratio | 1.13 |
| PB Ratio | 0.98 |
| P/TBV Ratio | 0.98 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 10.54 |
| EV / Sales | 1.13 |
| EV / EBITDA | 5.94 |
| EV / EBIT | 6.26 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.53, with a Debt / Equity ratio of 0.07.
| Current Ratio | 7.53 |
| Quick Ratio | 5.33 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.43 |
| Debt / FCF | -0.37 |
| Interest Coverage | 13.49 |
Financial Efficiency
Return on equity (ROE) is 11.15% and return on invested capital (ROIC) is 9.54%.
| Return on Equity (ROE) | 11.15% |
| Return on Assets (ROA) | 9.63% |
| Return on Invested Capital (ROIC) | 9.54% |
| Return on Capital Employed (ROCE) | 15.38% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 7.54M |
| Profits Per Employee | 805,233 |
| Employee Count | n/a |
| Asset Turnover | 0.86 |
| Inventory Turnover | 2.01 |
Taxes
In the past 12 months, Sheel Biotech has paid 22.60 million in taxes.
| Income Tax | 22.60M |
| Effective Tax Rate | 16.12% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 65.91 |
| 200-Day Moving Average | 63.17 |
| Relative Strength Index (RSI) | 43.93 |
| Average Volume (20 Days) | 11,000 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sheel Biotech had revenue of INR 1.10 billion and earned 117.56 million in profits. Earnings per share was 6.69.
| Revenue | 1.10B |
| Gross Profit | 405.90M |
| Operating Income | 198.14M |
| Pretax Income | 140.16M |
| Net Income | 117.56M |
| EBITDA | 208.80M |
| EBIT | 198.14M |
| Earnings Per Share (EPS) | 6.69 |
Balance Sheet
The company has 91.78 million in cash and 89.79 million in debt, with a net cash position of 1.99 million or 0.10 per share.
| Cash & Cash Equivalents | 91.78M |
| Total Debt | 89.79M |
| Net Cash | 1.99M |
| Net Cash Per Share | 0.10 |
| Equity (Book Value) | 1.27B |
| Book Value Per Share | 62.40 |
| Working Capital | 1.11B |
Cash Flow
In the last 12 months, operating cash flow was -175.69 million and capital expenditures -66.60 million, giving a free cash flow of -242.28 million.
| Operating Cash Flow | -175.69M |
| Capital Expenditures | -66.60M |
| Depreciation & Amortization | 10.66M |
| Net Borrowing | -35.79M |
| Free Cash Flow | -242.28M |
| FCF Per Share | -11.90 |
Margins
Gross margin is 36.89%, with operating and profit margins of 18.01% and 10.69%.
| Gross Margin | 36.89% |
| Operating Margin | 18.01% |
| Pretax Margin | 12.74% |
| Profit Margin | 10.69% |
| EBITDA Margin | 18.98% |
| EBIT Margin | 18.01% |
| FCF Margin | n/a |
Dividends & Yields
Sheel Biotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.13% |
| Shareholder Yield | -19.13% |
| Earnings Yield | 9.47% |
| FCF Yield | -19.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sheel Biotech has an Altman Z-Score of 7.43 and a Piotroski F-Score of 5.
| Altman Z-Score | 7.43 |
| Piotroski F-Score | 5 |